protocolSection identificationModule nctId: NCT06297850, orgStudyIdInfo id: WARD-Glucose Validation v.2.2, briefTitle: Accuracy of Continuous Glucose Monitoring in Patients With Diabetes. A Prospective Observational Study, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2024-09-30, completionDateStruct date: 2025-05-01, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: University Hospital Bispebjerg and Frederiksberg, class: OTHER, collaborators name: Rigshospitalet, Denmark, collaborators name: Steno Diabetes Center Copenhagen, collaborators name: Zealand University Hospital, descriptionModule briefSummary: The goal of this observational study is to investigate the accuracy of the continuous glucose monitoring (CGM) compared to standard point-of-care (POC) blood glucose measurements in patients with diabetes in patients who during their hospital admission can experience circulatory impairment.The main questions it aims to answer are:• Do CGM measurements have a decreased accuracy compared to standard blood glucose measurements in periods with circulatory impairment?Participants will be asked to wear a blinded CGM device (Dexcom G7, Dexcom Inc.) during their stay in the hospital but will receive standard care of their diabetes. The CGM device will be worn for up to 10 days., conditionsModule conditions: Diabetes Mellitus, conditions: Dysglycemia, conditions: Perioperative Complication, conditions: Circulatory; Complications, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Dexcom G7 Continuous Glucose Monitoring (CGM) System (G7), outcomesModule primaryOutcomes measure: Agreement between glucose, secondaryOutcomes measure: Agreement between glucose readings when at low glucose levels, secondaryOutcomes measure: Agreement between glucose readings when at normal glucose levels, secondaryOutcomes measure: Agreement between glucose readings when at high glucose levels, otherOutcomes measure: Adverse clinical outcomes, otherOutcomes measure: Readmission, otherOutcomes measure: Mortality, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Department of Anaesthesiology, Centre for Cancer and Organ Diseases, Rigshospitalet, status: RECRUITING, city: Copenhagen, state: The Capital Region Of Denmark, zip: 2100, country: Denmark, contacts name: Eske K Aasvang, MD, DMSc, role: CONTACT, email: eske.kvanner.aasvang.01@regionh.dk, geoPoint lat: 55.67594, lon: 12.56553, locations facility: Department of Anaesthesiology and Intensive Care, Bispebjerg Hospital, status: RECRUITING, city: Copenhagen, state: The Capital Region Of Denmark, zip: 2400, country: Denmark, contacts name: Christian S Meyhoff, MD, PhD, role: CONTACT, email: christian.sylvest.meyhoff@regionh.dk, geoPoint lat: 55.67594, lon: 12.56553, locations facility: Department of Orthopaedic Surgery and Traumatology, Bispebjerg and Frederiksberg Hospital, status: RECRUITING, city: Copenhagen, state: The Capital Region Of Denmark, zip: 2400, country: Denmark, contacts name: Henrik Palm, MD, DMSc, role: CONTACT, email: henrik.palm@regionh.dk, geoPoint lat: 55.67594, lon: 12.56553, locations facility: Surgical department, Bispebjerg and Frederiksberg Hospital,, status: NOT_YET_RECRUITING, city: Copenhagen, state: The Capital Region Of Denmark, zip: 2400, country: Denmark, contacts name: Lars N Jørgensen, MD, DMSc, role: CONTACT, email: lars.nannestad.joergensen@regionh.dk, geoPoint lat: 55.67594, lon: 12.56553, hasResults: False